Compare CTBI & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTBI | OCUL |
|---|---|---|
| Founded | 1903 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1995 | 2014 |
| Metric | CTBI | OCUL |
|---|---|---|
| Price | $70.92 | $6.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $81.33 | $26.00 |
| AVG Volume (30 Days) | 119.6K | ★ 3.7M |
| Earning Date | 10-21-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.16% | N/A |
| EPS Growth | ★ 17.79 | N/A |
| EPS | ★ 3.14 | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $10.44 | $1.71 |
| Revenue Next Year | $4.55 | $93.12 |
| P/E Ratio | $21.73 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $50.25 | $6.00 |
| 52 Week High | $79.92 | $16.44 |
| Indicator | CTBI | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 39.59 | 33.25 |
| Support Level | $64.34 | $6.23 |
| Resistance Level | $71.28 | $9.93 |
| Average True Range (ATR) | 1.99 | 0.44 |
| MACD | -0.41 | -0.01 |
| Stochastic Oscillator | 41.92 | 34.00 |
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.